Abstract
A 19-year-old male healthy hepatitis B virus (HBV) carrier developed fulminant hepatitis following allogenic bone marrow transplantation (BMT) from his brother, who was also a healthy HBV carrier, during the first complete remission of acute myelogenic leukemia (M1, FAB classification). Serum markers related to both HBV and hepatitis C virus (HCV) were elevated during active liver injury when a point mutation in the precore (pre-C) region occurred in the HBV. The patient received low-dose interferon alpha (IFN-α), while the dose of cyclosporin A was tapered; the patient eventually recovered from the liver injury. Fulminant hepatitis due to HBV and/or HCV following BMT is rare, and it is considered to have a very poor prognosis. The rationale for the use of low-dose IFN-α with cyclosporin A (CyA) is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sherlock S, Dooley J. Hepatic encephalopathy. Diseases of the liver and biliary system. 9th ed. Oxford: Blackwell Scientific Publications, 1993;88.
Pariente EA, Goudeau A, Dubois F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogenic bone marrow transplantation. Dig Dis Sci 1988;33: 1185–1191.
Chen P, Fan S, Liu C, et al. Changing of hepatitis B virus markers in patients with bone marrow transplatation. Transplantation 1990;49:708–713.
Locasciulli A, Bacigalupo A, Van Lint MT, et al. Hepatitis B virus (HBV) infection and liver disease after allogenic bone marrow transplantation: a report of 30 cases. Bone Marrow Tran plant 1990;6:25–29.
Webster A, Brenner MK, Prentice HG, et al. Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transplant 1989;4:207–208.
Kanamori H, Fukawa H, Maruta A, et al. Fulminant hepatitis C viral infection after allogenic bone marrow transplantation. Am J Med Sci 1992;303:109–111.
Yoshiba M, Sekiyama K, Sugata F, et al. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992;8:1253–1259.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Omata, F., Ueno, F., Kushibiki, Y. et al. Fulminant hepatitis following bone marrow transplantation in hepatitis B virus carrier siblings. J Gastroenterol 29, 653–655 (1994). https://doi.org/10.1007/BF02365451
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02365451